Stereotactic radiation therapy (SRT) is a method used to deliver a curative dose of external beam radiation therapy. With rapid dose drop-off and precision radiation targeting, this treatment enables for very high doses of radiation to be given without increasing the toxicity to adjacent normal tissues. By altering DNA, this treatment destroys cancer cells or slows their proliferation. The market is expected to be further fueled by elements including government initiatives, rising investments in the veterinary healthcare sector, and quickening technology breakthroughs in noninvasive SRS systems.
Frequently Asked Questions
The market is segmented based on Segmentation, By Product (Microsurgical Instrumentation, Optical/Viewing Instruments and Others), Modality Type (Gamma Knife, Linear Accelerator, Particle Beam Radiation therapy, Cyber Knife) - Industry Trends and Forecast to 2032
.
The Global Veterinary Stereotactic Radiosurgery System Market size was valued at USD 512.93 USD Million in 2024.
The Global Veterinary Stereotactic Radiosurgery System Market is projected to grow at a CAGR of 5.25% during the forecast period of 2025 to 2032.
The major players operating in the market include PetCure Oncology , Varian Medical SystemsInc. , Accuray Incorporated , BD , C. R. BardInc. , Eckert &, Ziegler , Elekta , HitachiLtd. , IntraOp MedicalInc. , Ion Beam Applications SA , IsorayInc. , Mevion Medical Systems .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
